Create a narrative

Amicus Therapeutics Community

NasdaqGM:FOLD Community

1 Narratives written by author
0 Comments on narratives written by author
26 Fair Values set on narratives written by author

Create a narrative

Amicus Therapeutics

AN

AnalystConsensusTarget

Consensus Narrative from 11 Analysts

Dimerix Collaboration Will Open Opportunities In US And Europe

Key Takeaways Strategic partnerships, robust product launches, and market diversification are key drivers of expected future revenue growth for Amicus Therapeutics. Maintaining financial discipline and onshoring production will enhance profitability and supply chain resilience, boosting earnings and margins.

US$15.82

FV

60.9% undervalued

21.58%

Revenue growth p.a.

0

0

0

New